{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Gil-Gil T"],"funding":["MEC | Instituto de Salud Carlos III","Comunidad de Madrid","Ministerio de Economía, Industria y Competitividad, Gobierno de España"],"pagination":["e00282-20"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8534728"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["5(3)"],"pubmed_abstract":["Fosfomycin is a bactericidal antibiotic, analogous to phosphoenolpyruvate, that exerts its activity by inhibiting the activity of MurA. This enzyme catalyzes the first step of peptidoglycan biosynthesis, the transfer of enolpyruvate from phosphoenolpyruvate to uridine-diphosphate-<i>N</i>-acetylglucosamine. Fosfomycin is increasingly being used, mainly for treating infections caused by Gram-negative multidrug-resistant bacteria. The mechanisms of mutational resistance to fosfomycin in <i>Stenotrophomonas maltophilia</i>, an opportunistic pathogen characterized by its low susceptibility to commonly used antibiotics, were studied in the current work. None of the mechanisms reported so far for other organisms, which include the production of fosfomycin-inactivating enzymes, target modificatio"],"journal":["mSystems"],"pubmed_title":["The Inactivation of Enzymes Belonging to the Central Carbon Metabolism Is a Novel Mechanism of Developing Antibiotic Resistance."],"pmcid":["PMC8534728"],"funding_grant_id":["RD16/0016/0011","S2017/BMD-3691","BIO2017-83128-R"],"pubmed_authors":["Gil-Gil T","Corona F","Martinez JL","Bernardini A"],"additional_accession":[]},"is_claimable":false,"name":"The Inactivation of Enzymes Belonging to the Central Carbon Metabolism Is a Novel Mechanism of Developing Antibiotic Resistance.","description":"Fosfomycin is a bactericidal antibiotic, analogous to phosphoenolpyruvate, that exerts its activity by inhibiting the activity of MurA. This enzyme catalyzes the first step of peptidoglycan biosynthesis, the transfer of enolpyruvate from phosphoenolpyruvate to uridine-diphosphate-<i>N</i>-acetylglucosamine. Fosfomycin is increasingly being used, mainly for treating infections caused by Gram-negative multidrug-resistant bacteria. The mechanisms of mutational resistance to fosfomycin in <i>Stenotrophomonas maltophilia</i>, an opportunistic pathogen characterized by its low susceptibility to commonly used antibiotics, were studied in the current work. None of the mechanisms reported so far for other organisms, which include the production of fosfomycin-inactivating enzymes, target modificatio","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Jun","modification":"2026-06-17T06:24:35.146Z","creation":"2025-04-06T12:44:24.993Z"},"accession":"S-EPMC8534728","cross_references":{"pubmed":["32487742"],"doi":["10.1128/mSystems.00282-20"]}}